Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 25:12:672208.
doi: 10.3389/fneur.2021.672208. eCollection 2021.

A Novel Management Platform Based on Personalized Home Care Pathways for Medicine Management and Rehabilitation of Persons With Parkinson's Disease-Requirements and Implementation Plan of the Care-PD Program

Song Gao  1 , Yuning Hou  1 , Renyan Ma  1 , Keneilwe Kenny Kaudimba  1 , Lingjing Jin  2 , Han Wang  3 , Ru Wang  1
Affiliations

A Novel Management Platform Based on Personalized Home Care Pathways for Medicine Management and Rehabilitation of Persons With Parkinson's Disease-Requirements and Implementation Plan of the Care-PD Program

Song Gao et al. Front Neurol. .

Abstract

As the percentage of the aging population increases, the incidence of Parkinson's disease (PD) in China is increasing year by year. PD is both a public health and social problem facing the government and society as a whole. Persons with PD need reasonable medication management and rehabilitation strategies after a clear diagnosis. A proper home care plan can effectively slow the progression of PD. However, people with PD lack an effective way to manage their illnesses and cannot achieve the recommended clinical path in a family environment. Medication management, condition monitoring, and rehabilitation training are important components of the home care plan for PD. Persons with PD require strategies that delay the development of the disease and to adhere to treatment, which would contribute to improving their quality of life. Thus, we developed a small program called Care-PD to build a medicine management and service platform for PD. The development of Care-PD is a multi-dimensional model designed for PD, which is funded by the National Key R&D Program of China (No. 2018YFC1314700), and includes services such as medication management, symptom monitoring, professional counseling, home life, and community communication. Care-PD can become a key technology that increases the compliance of persons with PD with home care plans and improve measures to control the disease. In this article, we describe the medication management and services for PD based on the Care-PD program and its structure. The small program will improve the adverse conditions faced by persons with PD by combining the latest technology and clinical approaches. Meanwhile, we describe a verification strategy to evaluate the effectiveness of the Care-PD program as a comprehensive management strategy for PD.

Keywords: Parkinson's disease; care-PD program; home care plan; medicine management; rehabilitation; telemedicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The main interface of the Care-PD program: (A) Prescription Management; (B) Medication Recording; (C) Effect Recording; (D) Adverse Report; (E) Patient's Diary; (F) Self-Assessment; (G) Research and Recruitment; (H) Exploratory.
Figure 2
Figure 2
Overview of the Care-PD architecture.
Figure 3
Figure 3
Work flow of the Care-PD program.
Figure 4
Figure 4
The Cloud Architecture.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ezzati M, Pearson-Stuttard J, Bennett JE, Mathers CD. Acting on non-communicable diseases in low- and middle-income tropical countries. Nature. (2018) 559:507–16. 10.1038/s41586-018-0306-9 - DOI - PubMed
    1. Radi E, Formichi P, Battisti C, Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis. (2014) 42(Suppl. 3):S125–52. 10.3233/JAD-132738 - DOI - PubMed
    1. Budd Haeberlein SL, Harris TJR. Promising targets for the treatment of neurodegenerative diseases. Clin Pharmacol Ther. (2015) 98:492–501. 10.1002/cpt.195 - DOI - PubMed
    1. Cacabelos R. Parkinson's disease: from pathogenesis to pharmacogenomics. Int J Mol Sci. (2017) 18:551. 10.3390/ijms18030551 - DOI - PMC - PubMed
    1. Chen W, Xu Z-M, Wang G, Chen S-D. Non-motor symptoms of Parkinson's disease in China: a review of the literature. Parkinsonism Relat Disord. (2012) 18:446–52. 10.1016/j.parkreldis.2012.02.002 - DOI - PubMed